European Guidelines for Prevention and Management of Influenza in Hematopoietic Stem Cell Transplantation and Leukemia Patients: Summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN

A clinical practice guideline for patients with leukemia or hematopoietic stem cell transplantation who are immunocompromised. The guideline examines the prevention and management of influenza in patients at high risk of morbidity and mortality, specifically diagnosis through reverse transcriptase multiplex real-time polymerase chain reaction. Outcomes of interest include clarified vaccination timing and criteria and improved antiviral recommendations for neuraminidase inhibitors.